Synbio Technologies
PrivateLast Round
Private Equity
Jan 5, 2023
Total Funding Raised
$3.66M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synbio Technologies is a synthetic biology company that provides DNA synthesis, gene synthesis, and other molecular biology services and products for researchers.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synbio Technologies Comparables
Compare Synbio Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenScript | 85% | |
| Biomatik Corporation | 83% | |
| Elegen | 81% |
Synbio Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jan 5, 2023 | ||||
| Private Placement | Mar 5, 2019 | ||||
| Private Placement | Jul 24, 2018 | ||||
| Private Placement | Oct 9, 2017 | ||||
| Series B | Jul 14, 2016 | ||||
Series A | Aug 28, 2014 |
Key People
Founding team and executive leadership
Synbio Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Private Placement, Series B |
| Co-Win Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 74% MoM.
- Mar 5, 2019
$8M round with Kaitai Capital participating.
Synbio Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synbio Technologies's valuation, stock price, and market status.
Is Synbio Technologies a public or private company?
Synbio Technologies is a private company.
What is the current stock price of Synbio Technologies?
Synbio Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is Synbio Technologies worth (valuation)?
Valuation information for Synbio Technologies is not publicly available.
Can I buy Synbio Technologies stock?
Synbio Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synbio Technologies's last funding round?
Synbio Technologies's most recent funding round was Private Equity on January 5, 2023.
Who are the main investors in Synbio Technologies?
Key investors in Synbio Technologies include Kaitai Capital, Co-Win Ventures.
Will Synbio Technologies IPO soon?
No public IPO plans have been announced for Synbio Technologies.
How can I track Synbio Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synbio Technologies's secondary market activity and sign up for updates.